PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Clinical trials for PERIPHERAL BLOOD STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL BLOOD STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for PERIPHERAL BLOOD STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a lower dose of a transplant drug be better for blood cancer patients?
Disease control Recruiting nowThis study is testing whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant, can prevent graft-versus-host disease (a common complication where donor cells attack the patient's body) while still being effective. The trial involves 260 adults with b…
Matched conditions: PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug combo aims to stop leukemia relapse after transplant
Disease control Recruiting nowThis study tests whether adding two drugs (ruxolitinib and chidamide) to standard chemotherapy before a stem cell transplant can lower the chance of leukemia coming back. It involves 50 people aged 12–65 with high-risk B-cell acute lymphoblastic leukemia who have a suitable donor…
Matched conditions: PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC